Abnormal expression of c-Myc in human bronchial epithelial cells malignantly transformed by anti-BPDE

Abstract

Anti-benzo[a]pyrene-7,8-diol-9,10-epoxide (anti-BPDE) is a metabolite of benzo[a]pyrene (B[a]P) and acts as a potent mutagen in mammalian systems. However, molecular mechanisms related to anti-BPDE-induced carcinogenesis are poorly understood. Here, we investigated the expression of proto-oncogene c-myc in human bronchial epithelial cells (16HBE-T) transformed by exposure to anti-BPDE. The levels of mRNA and protein of c-Myc were examined in the 16HBE-T and vehicle-treated control cells (16HBE-N) by using different methods respectively, including reverse transcriptase-polymerase chain reaction (RT-PCR), quantitative real-time PCR (Q-PCR), western blot and immunocytochemical methods. The level of c-myc mRNA appeared to be significantly increased in 16HBE-T, as compared with those of the 16HBE-N. Likewise, the expression of c-Myc protein was significantly enhanced as compared with those of the control cells. Moreover, the localization of c-Myc protein shows mainly nuclear staining in 16HBE-T. In conclusion, the abnormal expression of c-Myc was present in anti-BPDE malignantly transformed 16HBE cells, which may be involved in the carcinogenesis molecular mechanism of anti-BPDE.

References

1. Pavanello S, Pulliero A, Saia B O, Clonfero E . Determinantsof anti-benzo[a]pyrene diol epoxide-DNA adduct formation in lymphomonocytesof the general population. Mutat Res, 2006, 611(1–2): 54–63
2. Burdick A D, Davis J W 2nd, Liu K J, Hudson L G, Shi H, Monske M L, Burchiel S W . Benzo(a)pyrene quinones increase cellproliferation, generate reactive oxygen species, and transactivatethe epidermal growth factor receptor in breast epithelial cells. Cancer Res, 2003, 63(22): 7825–7833
3. Gunter M J, Divi R L, Kulldorff M, Vermeulen R, Haverkos K J, Kuo M M, Strickland P, Poirier M C, Rothman N . Sinha R. Leukocyte polycyclic aromatic hydrocarbon-DNAadduct formation and colorectal adenoma. Carcinogenesis, 2007, 28(7): 1426–1429. doi:10.1093/carcin/bgm022
4. Conney A H . Induction of microsomal enzymes by foreign chemicals and carcinogenesisby polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res, 1982, 42(12): 4875–4917
5. Rojas M, Marie B, Vignaud J M, Martinet N, Siat J, Grosdidier G, Cascorbi I . AlexandrovK. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchialepithelial cells from patients with lung cancer: comparison with lungparenchyma. Cancer Lett, 2004, 207(2): 157–163. doi:10.1016/j.canlet.2003.11.016
6. Schwerdtle T, Seidel A, Hartwig A . Effect of soluble and particulate nickel compounds onthe formation and repair of stable benzo[a]pyrene DNA adducts in humanlung cells. Carcinogenesis, 2002, 23(1): 47–53. doi:10.1093/carcin/23.1.47
7. Denissenko M F, Pao A, Tang M, Pfeifer G P . Preferential formation of benzo[a]pyrene adducts at lung cancer mutationalhotspots in P53. Science, 1996, 274(5286): 430–432. doi:10.1126/science.274.5286.430
8. Shen Y M, Troxel A B, Vedantam S, Penning T M . Field J. Comparison of p53 mutations induced by PAH o-quinones withthose caused by anti-benzo[a]pyrene diol epoxide in vitro: role ofreactive oxygen and biological selection. Chem Res Toxicol, 2006, 19(11): 1441–1450. doi:10.1021/tx0601206
9. Wu X, Zhao Y, Honn S E, Tomlinson G E, Minna J D, Hong W K, Spitz M R . Benzo[a]pyrenediol epoxide-induced 3p21.3 aberrations and genetic predispositionto lung cancer. Cancer Res, 1998, 58(8): 1605–1608
10. Pavanello S, Favretto D, Brugnone F, Mastrangelo G, Dal Pra G, Clonfero E . HPLC/fluorescence determination of anti-BPDE-DNA adductsin mononuclear white blood cells from PAH-exposed humans. Carcinogenesis, 1999, 20(3): 431–435. doi:10.1093/carcin/20.3.431
11. Srivastava S K, Bansal P, Oguri T, Lazo J S, Singh S V . Cell division cycle 25B phosphatase isessential for benzo(a)pyrene-7,8-Diol-9,10-epoxide induced neoplastictransformation. Cancer Res, 2007, 67(19): 9150–9157. doi:10.1158/0008-5472.CAN-07-0025
12. Nasi S, Ciarapica R, Jucker R, Rosati J and Soucek L . Making decisions through Myc. FEBS Letters, 2001, 490(3): 153–162. doi:10.1016/S0014-5793(01)02118-4
13. Richardson G E, Johnson B E . The biology of lung cancer. Semin Oncol, 1993, 20(2): 105–127
14. Broers J L, Viallet J, Jensen S M, Pas H, Travis W D, Minna J D, Linnoila R I . Expression of c-myc in progenitorcells of the bronchopulmonary epithelium and in a large number ofnon-small cell lung cancers. Am J RespirCell Mol Biol, 1993, 9(1): 33–43
15. Zajac-Kaye M . Myconcogene: a key component in cell cycle regulation and its implicationfor lung cancer. Lung Cancer, 2001, 34(Suppl 2): S43–S46. doi:10.1016/S0169-5002(01)00343-9
16. Jiang Y, Chen J . Chen X. Malignant transformationof human bronchial epithelial cells induced by benzo(a)pyrene metabolitedihydroxyepoxy benzo pyrene. Weisheng Yanjiu, 2001, 30(3): 129–131 (in Chinese)
17. Quattrone A Papucci L, Santini V, Schiavone N, Noferini D, Calastretti A, Copreni E, Morelli S, Rossi Ferrini P L, Nicolin A, Capaccioli S . Quantitationof bcl-2 oncogene in cultured lymphoma/leukemia cell lines and inprimary leukemia B-cells by a highly sensitive RT-PCR method. Haematologica, 1995, 80(6): 495–504
18. Akerman G S, Rosenzweig B A, Domon O E, McGarrity L J, Blankenship L R, Tsai C A, Culp S J, MacGregor J T, Sistare F D, Chen J J, Morris S M . Gene expression profiles and geneticdamage in benzo(a)pyrene diol epoxide-exposed TK6 cells. Mutat Res, 2004, 549(1–2): 43–64
19. Castorina A, Tiralongo A, Cavallo D, Loreto C, Carnazza M L, Iavicoli S, Agata V D . Expression profile of ErbBreceptor's family in human alveolar type 2-like cell line A549 exposedto hexavalent chromium. Toxicol in Vitro, 2008, 22(2): 541–547. doi:10.1016/j.tiv.2007.10.003
20. Goidin D, Mamessier A, Staquet M J, Schmitt D, Berthier-Vergnes O . Ribosomal 18S RNA prevailsover glyceraldehyde-3-phosphate dehydrogenase and b-actin genes asinternal standard for quantitative comparison of mRNA levels in invasiveand non invasive human melanoma cell subpopulations. Anal Biochem, 2001, 295(1): 17–21. doi:10.1006/abio.2001.5171
21. IARC, International Agency for Research onCancer . IARC monographs on the evaluationof carcinogenic risks to humans, Air pollution. Part I. Some non-heterocyclicpolycyclic aromatic hydrocarbons and some related industrial exposures. Lyon, 2005, 92, in preparation
22. Fu J, Jiang Y G, Bin X N, Ji W D, Wang M . Effect of chlorophyllin on malignanttransformation cell cycle and proliferation in vitro in human bronchialepithelial cells. Zhongguo Gonggong Weisheng, 2005, 21(4): 423–424 (in Chinese)
23. Boxer1 L M, Dang C V . Translocations involvingc-myc and c-myc function. Oncogene. 2001, 20(40): 5595–5610
24. Dang C V . c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol, 1999, 19(1): 1–11
25. Little C D, Nam M M, Carney D N, Gazdar A F, Minna J D . Amplification and expression. of thec-myc oncogene in human lung cancer cell lines. Nature, 1983, 306(5939): 194–196. doi:10.1038/306194a0
26. Gosney J R, Field J K, Gosney M A, Lye M D, Spandidos D A, Butt S A . c-myc oncoprotein in bronchial carcinoma: expressionin all major morphological types. AnticancerRes, 1990, 10(3): 623–628
27. Popescu N C, Zimonjic D B . Chromosome-mediated alterationsof the MYC gene in human cancer. J CellMol Med, 2002, 6 (2): 151–159. doi:10.1111/j.1582-4934.2002.tb00183.x
28. Fields W R, Desiderio J G, Leonard R M, Burger E E, Brown B G, Doolittle D J . Differential c-myc expression profiles in normal human bronchialepithelial cells following treatment with benzo[a]pyrene, benzo[a]pyrene-4,5epoxide, and benzo[a]Pyrene-7,8-9,10 diol epoxide. Mol Carcinog, 2004, 40(2): 79–89. doi:10.1002/mc.20023